Literature DB >> 16602449

Evaluation of the national health policy of thalassaemia screening in the Islamic Republic of Iran.

N Ghotbi1, T Tsukatani.   

Abstract

We reviewed the medical and economic burden of thalassaemia major with emphasis on prenatal diagnosis for disease prevention as the most economic health care policy approach. The current programme in the Islamic Republic of Iran screens couples just before marriage, identifies carriers and refers them for genetic counselling. We searched the current literature for a refined model and enquired into compliance issues in interviews with physicians, couples and families with affected children. The programme was unsatisfactory in comparison with comparable programmes in the Mediterranean region. We devised a simple decision tree that incorporates cost-effectiveness and technical, methodological and social issues that affect compliance. While revisions to the policy could improve efficiency, follow-up is needed, especially to provide prenatal diagnosis for carrier couples.

Entities:  

Mesh:

Year:  2005        PMID: 16602449

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  15 in total

Review 1.  Carrier screening for beta-thalassaemia: a review of international practice.

Authors:  Nicole E Cousens; Clara L Gaff; Sylvia A Metcalfe; Martin B Delatycki
Journal:  Eur J Hum Genet       Date:  2010-06-23       Impact factor: 4.246

2.  Attitudes and beliefs among high- and low-risk population groups towards β-thalassemia prevention: a cross-sectional descriptive study from India.

Authors:  Swati Chawla; Rajnish Kumar Singh; Bhaskar V K S Lakkakula; Raghavendra Rao Vadlamudi
Journal:  J Community Genet       Date:  2017-04-06

3.  Decisions Regarding Pregnancy Termination Due to β-Thalassemia Major: a Mixed-Methods Study in Sistan and Baluchestan, Iran.

Authors:  Zahra Moudi; Ebrahim Miri-Moghaddam
Journal:  J Genet Couns       Date:  2016-09-28       Impact factor: 2.537

4.  Detection of responsible mutations for beta thalassemia in the Kermanshah Province of Iran using PCR-based techniques.

Authors:  Zohreh Rahimi; Adriana Muniz; Abbas Parsian
Journal:  Mol Biol Rep       Date:  2009-05-13       Impact factor: 2.316

5.  Ethical, social, and cultural issues related to clinical genetic testing and counseling in low- and middle-income countries: a systematic review.

Authors:  Adrina Zhong; Benedict Darren; Bethina Loiseau; Li Qun Betty He; Trillium Chang; Jessica Hill; Helen Dimaras
Journal:  Genet Med       Date:  2018-08-03       Impact factor: 8.822

Review 6.  Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran.

Authors:  Zohreh Rahimi
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

7.  High School Knowledge and Attitudes towards Thalassemia in Southeastern Iran.

Authors:  Ebrahim Miri-Moghaddam; Eisa Motaharitabar; Leila Erfannia; Alireza Dashipour; Marziyeh Houshvar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014

8.  Prevention of β Thalassemia in Northern Israel - a Cost-Benefit Analysis.

Authors:  Ariel Koren; Lora Profeta; Luci Zalman; Haya Palmor; Carina Levin; Ronit Bril Zamir; Stavit Shalev; Orna Blondheim
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-02-17       Impact factor: 2.576

9.  Evaluation and cost analysis of national health policy of thalassaemia screening in west-azerbaijan province of iran.

Authors:  Elham Ahmadnezhad; Nariman Sepehrvand; Farshid Fayyaz Jahani; Sanaz Hatami; Catauon Kargar; Majid Mirmohammadkhani; Shahrzad Bazargan-Hejazi
Journal:  Int J Prev Med       Date:  2012-10

10.  Molecular analysis of exons 6 and 7 of phenylalanine hydroxylase gene mutations in Phenylketonuria patients in Western Iran.

Authors:  Keyvan Moradi; Reza Alibakhshi; Keyghobad Ghadiri; Saeid Reza Khatami; Hamid Galehdari
Journal:  Indian J Hum Genet       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.